- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00877396
Hutterite Influenza Prevention Study
Does Vaccinating Health Hutterite Children Against Influenza Prevent Influenza in Other Hutterite Colony Members: A Randomized Cluster Trial
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Colonies will be enrolled in September 2008.
Healthy Hutterite Children will be vaccinated in October, in each year of the study (2008, 2009, & 2010)
Influenza Surveillance phase will begin around December-January of each year.
- All study outcomes will be collected during the Surveillance phase of the study from Dec to June for 3 years.
- Outcomes will be collected when research nurses visit the colonies. A research nurse will visit enrolled colonies twice a week during the surveillance phase and review study diaries and obtain swabs from participants with symptoms of influenza.
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 4
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Group A:
Inclusion Criteria:
- Hutterites other than the healthy children who will be immunized. Although this category as a whole will be used to assess indirect benefit of the vaccine in the main analysis, Hutterites at high risk for influenza complications within this category will be assessed in a separate analysis. These are defined as anyone in one or more of the following groups:
- individuals aged ≥ 65 years
- children 23 months of age or less
anyone with ≥ 1 of the following conditions severe enough to require regular medical follow-up or hospital care:
- chronic cardiac or pulmonary disorders (including bronchopulmonary dysplasia, cystic fibrosis, and asthma)
- diabetes mellitus and other metabolic diseases
- cancer
- immunodeficiency
- immunosuppression (due to underlying disease and/or therapy)
- renal disease
- anemia
- hemoglobinopathy
- any condition that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk of aspiration.
Exclusion Criteria:
- There are no exclusion criteria for this category of participants.
Group B:
Inclusion Criteria:
- Healthy children aged 36 months to 15 years who will be immunized as part of the intervention.
Exclusion Criteria:
- Anaphylactic reaction to a previous dose of influenza vaccine
- Anaphylactic reaction to hepatitis A vaccine
- Anaphylactic reaction to neomycin
- Known IgE-mediated hypersensitivity to eggs manifested as hives
- Swelling of the mouth and throat, difficulty in breathing, hypotension, or shock
- Guillain-Barré syndrome within eight weeks of a previous influenza vaccine.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verdrievoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Influenza
Inactivated Influenza vaccination
|
Influenza vaccination- 0.5 mL.
Children under 9 who have never received a influenza vaccine will receive a 2nd dose (0.5 mL) 4 weeks later.
Andere namen:
|
Placebo-vergelijker: Control
Hepatitis A vaccine
|
Hepatitis vaccination- 0.5 mL.
Children under 9 who have never received a influenza vaccine will receive a 2nd dose ( saline- 0.5 mL) 4 weeks later.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
laboratory-confirmed influenza infection
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
Influenza like illness
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Physician diagnosed otitis media
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
School or work related absenteeism
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Physician visits for respiratory illness
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Lower respiratory infection or pneumonia
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Hospitalizations for LRTI or pneumonia
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
All cause hospitalizations
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Deaths due to LRTI or pneumonia
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
All-cause deaths
Tijdsspanne: Dec to June each year for 3 years
|
Dec to June each year for 3 years
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Mark B Loeb, MD, McMaster University
Publicaties en nuttige links
Algemene publicaties
- Wang B, Russell ML, Moss L, Fonseca K, Earn DJ, Aoki F, Horsman G, Caeseele PV, Chokani K, Vooght M, Babiuk L, Webby R, Walter SD, Loeb M. Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial. PLoS One. 2016 Dec 15;11(12):e0167281. doi: 10.1371/journal.pone.0167281. eCollection 2016.
- Loeb M, Russell ML, Fonseca K, Webby R, Walter SD. Comparison of multiple estimates of efficacy for influenza vaccine. Vaccine. 2011 Dec 9;30(1):1-4. doi: 10.1016/j.vaccine.2011.10.069. Epub 2011 Nov 7.
- Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, Aoki F, Horsman G, Van Caeseele P, Chokani K, Vooght M, Babiuk L, Webby R, Walter SD. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010 Mar 10;303(10):943-50. doi: 10.1001/jama.2010.250.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MCT 88113
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Influenza
-
Gamaleya Research Institute of Epidemiology and...VoltooidGriep A | Influenza A-virusinfectie | Influenza-epidemie | Influenza H5N1Russische Federatie
-
Vanderbilt University Medical CenterHuman Vaccines ProjectVoltooidVaccin reactie | Influenza | Influenza, mens | Griep A | Influenza type B | Influenza A H3N2 | Influenza A H1N1Verenigde Staten
-
NPO PetrovaxVoltooidVaccin reactie | Influenza | Influenza, mens | Griep A | Acute luchtweginfectie | Influenza type B | Griep | Influenza A H3N2 | Influenza A H1N1 | Griep, mens | Influenza-epidemieRussische Federatie
-
Quidel CorporationVoltooidInfluenza A, Influenza BVerenigde Staten
-
Vaxine Pty LtdAustralian Respiratory and Sleep Medicine InstituteVoltooid
-
Ology BioservicesVoltooidInfluenza, vogelAustralië, Finland, Singapore, Spanje
-
National Institute of Allergy and Infectious Diseases...Voltooid
-
National Institute of Allergy and Infectious Diseases...Voltooid
-
National Institute of Allergy and Infectious Diseases...VoltooidInfluenza immunisatie | VogelgriepVerenigde Staten
-
National Institute of Allergy and Infectious Diseases...VoltooidInfluenza | Influenza immunisatie | VogelgriepVerenigde Staten
Klinische onderzoeken op Influenza vaccination
-
PfizerVoltooidInfluenza, mensVerenigde Staten
-
Johns Hopkins UniversityWervingInfluenza | Oudere volwassenen | Immunisatie | Ouder dan 75 jaarVerenigde Staten
-
University of ZurichSchweizerischer NationalfondsVoltooid
-
Nanogen, Inc.Geschorst
-
Fondazione Policlinico Universitario Agostino Gemelli...Voltooid
-
Hospices Civils de LyonNog niet aan het werven
-
Quidel CorporationVoltooidInfluenza A, Influenza BVerenigde Staten
-
Nanogen, Inc.Centers for Disease Control and PreventionGeschorst
-
Duke UniversityUnited States Department of Defense; Imperial College of LondonOnbekendGriep AVerenigd Koninkrijk
-
University of Wisconsin, MadisonQuidel CorporationVoltooid